KCTD8 Antikörper (AA 381-473) (FITC)
-
- Target Alle KCTD8 Antikörper anzeigen
- KCTD8 (Potassium Channel Tetramerisation Domain Containing 8 (KCTD8))
-
Bindungsspezifität
- AA 381-473
- Reaktivität
- Human, Maus
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser KCTD8 Antikörper ist konjugiert mit FITC
-
Applikation
- Western Blotting (WB), Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p))
- Kreuzreaktivität
- Human, Maus
- Homologie
- Rat,Dog,Cow,Sheep,Pig,Horse,Chicken,Rabbit
- Aufreinigung
- Purified by Protein A.
- Immunogen
- KLH conjugated synthetic peptide derived from human KCTD8
- Isotyp
- IgG
- Top Product
- Discover our top product KCTD8 Primärantikörper
-
-
- Applikationshinweise
-
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 μg/μL
- Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
- Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
- Haltbarkeit
- 12 months
-
- Target
- KCTD8 (Potassium Channel Tetramerisation Domain Containing 8 (KCTD8))
- Andere Bezeichnung
- KCTD8 (KCTD8 Produkte)
- Synonyme
- A730087N02Rik antikoerper, potassium channel tetramerisation domain containing 8 antikoerper, potassium channel tetramerization domain containing 8 antikoerper, Kctd8 antikoerper, KCTD8 antikoerper
- Hintergrund
-
Synonyms: BTB/POZ domain-containing protein KCTD8, KCTD8, KCTD8_HUMAN, Potassium channel tetramerisation domain containing 8.
Background: Auxiliary subunit of GABA-B receptors that determine the pharmacology and kinetics of the receptor response. Increases agonist potency and markedly alter the G-protein signaling of the receptors by accelerating onset and promoting desensitization.
- Pathways
- Regulation of G-Protein Coupled Receptor Protein Signaling
-